Literature DB >> 19483694

Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis.

Gurumoorthy Krishnamoorthy1, Amit Saxena, Lennart T Mars, Helena S Domingues, Reinhard Mentele, Avraham Ben-Nun, Hans Lassmann, Klaus Dornmair, Florian C Kurschus, Roland S Liblau, Hartmut Wekerle.   

Abstract

We describe here the paradoxical development of spontaneous experimental autoimmune encephalomyelitis (EAE) in transgenic mice expressing a myelin oligodendrocyte glycoprotein (MOG)-specific T cell antigen receptor (TCR) in the absence of MOG. We report that in Mog-deficient mice (Mog-/-), the autoimmune response by transgenic T cells is redirected to a neuronal cytoskeletal self antigen, neurofilament-M (NF-M). Although components of radically different protein classes, the cross-reacting major histocompatibility complex I-Ab-restricted epitope sequences of MOG35-55 and NF-M18-30 share essential TCR contact positions. This pattern of cross-reaction is not specific to the transgenic TCR but is also commonly seen in MOG35-55-I-Ab-reactive T cells. We propose that in the C57BL/6 mouse, MOG and NF-M response components add up to overcome the general resistance of this strain to experimental induction of autoimmunity. Similar cumulative responses against more than one autoantigen may have a role in spontaneously developing human autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483694     DOI: 10.1038/nm.1975

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  22 in total

1.  Myelination in rat brain: changes in myelin composition during brain maturation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

2.  Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.

Authors:  Estelle Bettelli; Dominique Baeten; Anneli Jäger; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

3.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

Authors:  Gurumoorthy Krishnamoorthy; Hans Lassmann; Hartmut Wekerle; Andreas Holz
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

4.  Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice.

Authors:  Avraham Ben-Nun; Nicole Kerlero de Rosbo; Nathali Kaushansky; Miriam Eisenstein; Lydia Cohen; Joel F Kaye; Itzhack Mendel
Journal:  Eur J Immunol       Date:  2006-02       Impact factor: 5.532

5.  Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits.

Authors:  H Jacomy; Q Zhu; S Couillard-Després; J M Beaulieu; J P Julien
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

6.  Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.

Authors:  T Berger; S Weerth; K Kojima; C Linington; H Wekerle; H Lassmann
Journal:  Lab Invest       Date:  1997-03       Impact factor: 5.662

7.  T cell responses to myelin basic protein in experimental autoimmune encephalomyelitis-resistant BALB/c mice.

Authors:  S Abromson-Leeman; M Hayashi; C Martin; R Sobel; A al-Sabbagh; H Weiner; M E Dorf
Journal:  J Neuroimmunol       Date:  1993-06       Impact factor: 3.478

8.  Characterization of MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide.

Authors:  Troels R Petersen; Estelle Bettelli; John Sidney; Alessandro Sette; Vijay Kuchroo; B Thomas Bäckström
Journal:  Eur J Immunol       Date:  2004-01       Impact factor: 5.532

9.  Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.

Authors:  Cécile Delarasse; Philippe Daubas; Lennart T Mars; Csaba Vizler; Tobias Litzenburger; Antonio Iglesias; Jan Bauer; Bruno Della Gaspera; Anna Schubart; Laurence Decker; Dalia Dimitri; Guy Roussel; Andrée Dierich; Sandra Amor; Andre Dautigny; Roland Liblau; Danielle Pham-Dinh
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Schwann cells of the myelin-forming phenotype express neurofilament protein NF-M.

Authors:  B M Kelly; C S Gillespie; D L Sherman; P J Brophy
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

View more
  66 in total

Review 1.  Fragile privileges: autoimmunity in brain and eye.

Authors:  Hartmut Wekerle; De-ming Sun
Journal:  Acta Pharmacol Sin       Date:  2010-09       Impact factor: 6.150

Review 2.  [Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system].

Authors:  O Aktas; J Ingwersen; B Kieseier; P Küry; R Hohlfeld; H-P Hartung
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

Review 3.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

Review 4.  Clinical potential of antigen-specific therapies in type 1 diabetes.

Authors:  Ken T Coppieters; Birgit Sehested Hansen; Matthias G von Herrath
Journal:  Rev Diabet Stud       Date:  2012-12-28

5.  Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Authors:  Nicolas Fissolo; Sabrina Haag; Katrien L de Graaf; Oliver Drews; Stefan Stevanovic; Hans Georg Rammensee; Robert Weissert
Journal:  Mol Cell Proteomics       Date:  2009-06-16       Impact factor: 5.911

6.  Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread.

Authors:  Anna E Kersh; Lindsay J Edwards; Brian D Evavold
Journal:  J Immunol       Date:  2014-09-29       Impact factor: 5.422

7.  Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Gregory F Wu; Chelsea R Parker Harp; Kenneth S Shindler
Journal:  Curr Immunol Rev       Date:  2015

Review 8.  CD4 T cells in immunity and immunotherapy of Alzheimer's disease.

Authors:  Alon Monsonego; Anna Nemirovsky; Idan Harpaz
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

9.  Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.

Authors:  Ralf A Linker; De-Hyung Lee
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.